Pyxis debuts next-gen cancer ADCs from under Pfizer's wing

Retrieved on: 2021-04-27 12:00:00

Tags for this article:

Clinical medicine

Life Sciences

Antibody-drug conjugate

Click the tags to see associated articles and topics

Pyxis debuts next-gen cancer ADCs from under Pfizer's wing. View article details on HISWAI: https://www.fiercebiotech.com/biotech/pyxis-debuts-next-gen-adcs-from-under-pfizer-s-wing

Excerpt

After raising a monster $152 million in a series B round last month, Pfizer darling Pyxis Oncology is ready to share more details about what it'll be ...

Article found on: www.fiercebiotech.com

View Original Article